The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his personal conduct," a government spokesperson said.
UniQure shares soared on positive AMT-130 Huntington's disease data, but plunged after the FDA reversed its stance on ...
Before you cast your ballot, here's what the candidates running in New Bedford's upcoming election had to say: ...
Shutdown pay: The U.S. military is accepting a private donation of $130 million to help pay the 1.3 million active duty troops during the government shutdown, the Defense Department said Friday. The ...
Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...
The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on ...
From a slew of data out of China and the UK, to the start of the U.N. climate change summit, these are the stories to watch ...
The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.
The Food and Drug Administration is recalling 16 brands of cinnamon that contain elevated lead levels, which over time can cause neurological problems including learning disabilities in young children ...
As excitement around animal testing alternatives reaches a fever pitch, Charles River Laboratories is making a move to strengthen its development of new approach methodologies (NAMs) that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback